Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.
D000409:Alanine; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D006834:Hydrazines / Q000494:pharmacology*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011748:Pyrogallol / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology*
D002395:Catecholamines; D006834:Hydrazines; D011748:Pyrogallol; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010088:Oxidoreductases; D000409:Alanine
BRAIN/metabolism; CATECHOLAMINES/metabolism; DOPA/pharmacology; HYDRAZINES/pharmacology; OXIDASES/antagonists; PYROGALLOL/pharmacology; RESERPINE/pharmacology